Product Images Doxorubicin Hydrochloride

HCI stands for Human-Computer Interaction, which is the study of designing, evaluating, and implementing interactive computing systems for human use and with consideration of the human perspective. It is an interdisciplinary field that combines knowledge and methodologies from computer science, psychology, design, anthropology, and other related disciplines with the goal of improving the usability, accessibility, and overall user experience in the interaction between humans and computers.*

The given text is a chemical formula with the molecular structure of a compound. The compound has a complex structure with three variations of chemical bonds, including C-O, C-N, and P-O. The compound also contains carbon, hydrogen, oxygen, nitrogen, and/or phosphorus atoms. The values of m and n are either 14 or 16.*

The text appears to be describing a type of coating called MPEG-DSPE coating which is applied to an aqueous core that contains doxorubicin HCI. The coated substance seems to have a liposomal bilayer structure.*

This is a description of a sterile injectable medication called DOXOrubicin Hydrochloride Liposome Injection. The medication is a cytotoxic agent, intended for intravenous infusion only. It comes in a 10mL single-dose vial and has a usual dosage, which can be found in the package insert. It is important to discard any unused portions and keep the vial refrigerated between 2 to 8°C (36 to 46°F) but not frozen. The medication is manufactured by Cadia Healthcare Limited in Ahmedabad, India, and is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

DOXOrubicin Hydrochloride Liposome Injection is a medication that may be used to treat certain types of cancer. Not available for further information due to limited text.*

This is a medication called DOXOrubicin Hydrochloride, which is a cytotoric agent used for intravenous infusion only. It comes in a sterile liposome injection format, with a usual dosage of 2mg/mL that must be diluted before use. The medication should be refrigerated at 2 to 8°C (36 to 46°F) and discarded after use. The manufacturer is not available, but it is distributed by Zydus Pharmaceuticals (USA) Inc. The package contains a 25mL single-dose vial, and it should not be frozen.*